Inhibrx

0 followers


Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.

Industries

Employees

51-200

Links


Org chart

Mark P. Lappe
Founder & CEO
Collapse
Kelly Deck
EVP & CFO
Ashraf Amanullah
EVP & Chief Technical Operations Officer
Leah Pollema
General Counsel
David Kao
VP, Regulatory Affairs
Vasily Andrianov
VP, Clinical Development & Medical Affairs
Dana Ebbets-Reed
VP, Quality Assurance
Darren Brown
VP, Analytical Development & Quality Control
Robert Boothroyd
VP, Medical Affairs & Business Development
Brian Lobo
VP, Formulation Development & Drug Product Manufacturing
Melissa Masterson
VP, Value, Access & Distribution
Susan W.
Senior Director Regulatory Affairs

Board & advisors

Mark Brantly
Scientific Advisor
Robert A. Sandhaus
Scientific Advisor
Kenneth R. Chapman
Scientific Advisor
James Stoller
Scientific Advisor
Noel Gerry McElvaney
Scientific Advisor
Igor Barjaktarevic
Scientific Advisor